Estudio longitudinal de la apatía en pacientes con enfermedad de Alzheimer

Turró‐Garriga, Oriol; López-Pousa, S; Vilalta-Franch, Joan; Turon-Estrada, Antoni; Pericot-Nierga, Imma; M, Lozano-Gallego; Hernández-Ferrándiz, M; Soler-Cors, Olga; Planas-Pujol, Xènia; Monserrat, Oriol; Garré-Olmo, Josep

doi:10.33588/rn.4801.2008565

Cited by 6 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…BPSD have been related to worse impairments in the functional and cognitive performance of patients [2,3] and are often confused with other psychiatric diagnoses [4]. In addition, BPSD are the major cause of institutionalization of AD patients and are a major concern for their caregivers [5].…”

Section: Introductionmentioning

confidence: 99%

Relationship between APOE, PER2, PER3 and OX2R Genetic Variants and Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease

Lozano-Tovar

Rodríguez-Agudelo

Montellano

et al. 2023

IJERPH

View full text Add to dashboard Cite

Alzheimer’s disease (AD) is characterized by the presence of neuropsychiatric or behavioral and psychological symptoms of dementia (BPSD). BPSD have been associated with the APOE_ε4 allele, which is also the major genetic AD risk factor. Although the involvement of some circadian genes and orexin receptors in sleep and behavioral disorders has been studied in some psychiatric pathologies, including AD, there are no studies considering gene–gene interactions. The associations of one variant in PER2, two in PER3, two in OX2R and two in APOE were evaluated in 31 AD patients and 31 cognitively healthy subjects. Genotyping was performed using real-time PCR and capillary electrophoresis from blood samples. The allelic-genotypic frequencies of variants were calculated for the sample study. We explored associations between allelic variants with BPSD in AD patients based on the NPI, PHQ-9 and sleeping disorders questionnaires. Our results showed that the APOE_ε4 allele is an AD risk variant (p = 0.03). The remaining genetic variants did not reveal significant differences between patients and controls. The PER3_rs228697 variant showed a nine-fold increased risk for circadian rhythm sleep–wake disorders in Mexican AD patients, and our gene–gene interaction analysis identified a novel interaction between PERIOD and APOE gene variants. These findings need to be further confirmed in larger samples.

show abstract